LARGACTIL 25 MG INJECTION/INFUSION SOLUTION IN AMPULES (10 AMPULES) – 2026 Price Turkey

Clinical Data Review: Comprehensive profile for LARGACTIL 25 MG INJECTION/INFUSION SOLUTION IN AMPULES (10 AMPULES), including its pharmacological composition, pricing in Turkey (2026), and regulatory status for international patients.

1. Pharmaceutical Profile

Proprietary Name: LARGACTIL 25 MG INJECTION/INFUSION SOLUTION IN AMPULES (10 AMPULES)

Manufacturer: EIP Eczacıbaşı Pharmaceutical Marketing Inc.

Registration Status: Licensed by T.C. Ministry of Health

Active Pharmaceutical Ingredient

KLORPROMAZIN 🔗

*Click to view bioequivalent formulations.

2. Therapeutic Indications

LARGACTIL 25 MG INJECTION/INFUSION SOLUTION IN AMPULES (10 AMPULES) is formulated with KLORPROMAZIN, a clinically established agent in medical practice.

  • Mechanism of Action: KLORPROMAZIN acts according to the pharmacological principles of its drug class to provide therapeutic relief.
  • Primary Use: Prescribed by healthcare professionals for conditions responsive to KLORPROMAZIN therapy.
  • Dosage Regimen: Please refer to the official Patient Information Leaflet (PIL) included in the packaging for specific dosing instructions relative to age and severity of symptoms.

3. Market Data & Pricing (2026)

Note: Drug prices in Turkey are regulated under the Reference Pricing System (SUT) enforced by the government.

Product Name LARGACTIL 25 MG INJECTION/INFUSION SOLUTION IN AMPULES (10 AMPULES)
Barcode (GTIN) 8699586750137
Generic Name KLORPROMAZIN
License Holder EIP Eczacıbaşı Pharmaceutical Marketing Inc.
Pharmacy Retail Price 169.71 TL
⚠️ Clinical Safety Warning

Do not administer LARGACTIL 25 MG INJECTION/INFUSION SOLUTION IN AMPULES (10 AMPULES) if the patient has a known hypersensitivity or allergy to KLORPROMAZIN. Purchase only from authorized pharmacies (Eczane) to ensure supply chain integrity.


Disclaimer: This content is compiled from public pharmaceutical records for informational purposes. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified physician regarding any medical condition.
Data Source: Product label via EIP Eczacıbaşı Pharmaceutical Marketing Inc..

Leave a Comment